IgA nephropathy: open trials in Belgium

• 2024-519638-22-00

  A clinical trial to learn about the long-term safety of FUB523 (zigakibart) in people with immunoglobulin A (IgA) nephropathy who have completed previous zigakibart trials

  Trial Treatment · Phase 3 · Novartis Pharma AG

  Imelda, Bonheiden · HUmani, Charleroi · Universitair Ziekenhuis Gent, Gent · Centre Hospitalier Universitaire de Liège, Liège · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe

  Registry updated 2026-10-30

• NCT07773727

  A Study to Evaluate the Effect of ARGX-121 on the Change in Proteinuria in Adult Participants With IgAN

  Trial Treatment · Phase 2 · argenx

  Ziekenhuis Oost-Limburg, Genk · Universitair Ziekenhuis Gent, Gent · UZ Brussel, Jette · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe

  Registry updated 2026-10-27

• NCT06935357

  A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)

  Trial Treatment · Phase 3 · Biogen

  Hopital Erasme, Anderlecht · Ziekenhuis Oost-Limburg, Genk · Jan Yperman Ziekenhuis, Ieper · Algemeen Ziekenhuis Groeninge, Kortrijk · UZ Leuven, Leuven · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe

  Registry updated 2026-10-14

• NCT04557462

  A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

  Trial Treatment · Phase 3 · Novartis Pharmaceuticals

  Antwerp University Hospital, Edegem · UZ Leuven, Leuven · Algemeen Ziekenhuis Delta, Roeselare

  Registry updated 2026-10-05

All IgA nephropathy trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error